MedTrace Logo

AISTCM-Outcome Measurement of Acute Ischemic Stroke With Traditional Chinese Medicine

NCT00351806 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2013-08-07

No results posted yet for this study

Summary

The purpose of this study is to determine whether Traditional Chinese Medicine (TCM) is able to improve the outcome of acute ischemic stroke and to observe its safety.

Conditions

  • Cerebral Infarction

Interventions

DRUG

Erigeron breviscapus injection

DRUG

hua tuo zai zao wan (a herbal medicine pill)

DRUG

Compound stroke herbal medicine (8 herbal)

Sponsors & Collaborators

  • Guangzhou University of Traditional Chinese Medicine

    lead OTHER

Principal Investigators

  • Longhui Yang, Chairmam · Branch of Science and Education

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-07-31
Completion
2006-11-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00351806 on ClinicalTrials.gov